Ebola outbreak DR Congo: over 2,000 cases confirmed

Focus in the East

Containment is being made more difficult by the characteristics of the currently circulating pathogen. As stated in the Deutschlandfunk report, this is the "Bundibugyo" type of the virus, for which there is currently neither a vaccine nor an approved therapy. The situation thus differs fundamentally from earlier outbreaks such as the one in 2018/2019 in North Kivu, where a vaccine could be deployed widely.

International organizations are supporting the Congolese authorities in containment efforts. In addition to the World Health Organization (WHO), further partners are involved in surveillance, laboratory work, and public information, according to information from the United States. Private aid organizations such as Médecins Sans Frontières are also active in the affected provinces.

Limited Treatment Options

Martin Grobusch, an infectious disease specialist with ties to clinical research on viral hemorrhagic fevers, had pointed out in earlier statements that therapy options for Bundibugyo are limited. Without a specific vaccine, only the consistent application of the classic measures remains: case isolation, contact tracing, safe handling of the deceased, and protection of healthcare workers.

However, capacities in the affected provinces are limited. Several treatment centers had to close temporarily or reduce their capacities in recent weeks, and aid deliveries to the region were impeded at times. Local aid organizations also complain about waning attention from international donors.

International Aid under Pressure

The World Health Organization had already classified the outbreak as a health emergency in the past months. In view of the rising case numbers once again and the lack of a specific vaccine, the WHO and aid organizations are calling for increased international support.

The pathogen was first identified in 2007 in the Ugandan district of Bundibugyo and has since spread repeatedly in East and Central Africa. In the current outbreak as well, a portion of the infections is fatal. Precise case fatality rates for this outbreak have not been publicly quantified to date.

The Congolese capital Kinshasa has so far not been designated as a large-scale outbreak area, though individual suspected cases continue to be investigated there. The authorities once again called on the population to practice hygiene and protective measures.

If the current trend continues, experts expect a further increase in documented cases in the coming weeks. International observers emphasize that the dynamics of the outbreak remain closely tied to the situation in the eastern provinces and depend there on the security situation, the population's trust, and the availability of protective materials.